Tenon Medical (NASDAQ:TNON) vs. Innovative Eyewear (NASDAQ:LUCY) Head-To-Head Comparison

Innovative Eyewear (NASDAQ:LUCY – Get Free Report) and Tenon Medical (NASDAQ:TNON – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, valuation and earnings.

Analyst Ratings

This is a breakdown of current ratings and target prices for Innovative Eyewear and Tenon Medical, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Innovative Eyewear 1 1 0 0 1.50
Tenon Medical 1 0 1 0 2.00

Risk & Volatility

Innovative Eyewear has a beta of 2.76, indicating that its stock price is 176% more volatile than the S&P 500. Comparatively, Tenon Medical has a beta of 1.36, indicating that its stock price is 36% more volatile than the S&P 500.

Institutional and Insider Ownership

1.0% of Innovative Eyewear shares are owned by institutional investors. Comparatively, 22.7% of Tenon Medical shares are owned by institutional investors. 1.7% of Innovative Eyewear shares are owned by company insiders. Comparatively, 17.7% of Tenon Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Innovative Eyewear and Tenon Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Innovative Eyewear -225.26% -88.90% -80.34%
Tenon Medical -257.85% -907.60% -124.84%

Valuation & Earnings

This table compares Innovative Eyewear and Tenon Medical”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Innovative Eyewear $2.66 million 3.02 -$7.59 million ($1.29) -0.72
Tenon Medical $3.94 million 0.46 -$12.56 million ($44.87) -0.06

Innovative Eyewear has higher earnings, but lower revenue than Tenon Medical. Innovative Eyewear is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

Summary

Innovative Eyewear beats Tenon Medical on 7 of the 13 factors compared between the two stocks.

About Innovative Eyewear

(Get Free Report)

Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.

About Tenon Medical

(Get Free Report)

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

Receive News & Ratings for Innovative Eyewear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovative Eyewear and related companies with MarketBeat.com's FREE daily email newsletter.